About Robert C. Malenka, MD, PhD
Malenka is an internationally acclaimed research scientist in the neurosciences. His scientific papers have been cited more than 120,000 times, providing foundational knowledge about the mechanisms of synaptic plasticity and modulation in the human brain. His laboratory continues to conduct research on the synaptic and circuit mechanisms that mediate behaviors related to a range of brain disorders, including addiction, autism and depression.
Current roles
- Chief Scientific Officer at Bayshore Global Management
- Pritzker Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine (Stanford Medicine)
- Director of the Nancy Prtizker Laboratory at Stanford Medicine
- Deputy Director of the Wu Tsai Neurosciences Institute at Stanford Medicine
Elections of note
- Elected member: National Academy of Sciences
- Elected member: National Academy of Medicine
- Elected fellow: American Academy of Arts and Sciences
- Elected fellow: American Association for the Advancement of Science
- Elected fellow: American College of Neuropsychopharmacology
Service of note
- Councilor: National Advisory Council on Drug Abuse
- Councilor: Society for Neuroscience
- Councilor: American College of Neuropsychopharmacology
Honors and awards
- Steven C. Beering Award for the Advancement of Biomedical Science, Indiana University School of Medicine (2024)
- Peter Seeberg Integrative Neuroscience Prize, Society for Neuroscience and Federation of European Neuroscience Societies (2022)
- Julius Axelrod Prize, Society for Neuroscience (2016)
- Julius Axelrod Mentorship Award, American College of Neuropsychopharmacology (2011)
- Medical Research Award in Neuropsychiatry, Robert and Claire Pasarow Foundation (2011)
- Member, National Academy of Sciences (2011)
- Fellow, American Association for the Advancement of Science (2009)
- Fellow, American Academy of Arts and Sciences (2005)
- Member, National Academy of Medicine (2004)
- Basic Neuroscience Research Award, Collegium Internationale Neuropsychopharmacologicum-Lilly (2002)
- International Prize in Neuroscience, Dargut and Milena Kemali Foundation (2000)
- Associate, Neurosciences Research Program (1999-2006)
- Daniel Efron Award, American College of Neuropsychopharmacology (1998)
- Distinguished Alumni Award, Stanford Medical School (1998)
- Young Investigator Award, Society for Neuroscience (1993)
Boards, advisory committees, professional organizations
- Scientific Advisory Board, Neurocampus, Bordeaux, France (2013 - Present)
- Co-Founder/Scientific Advisory Board, Circuit Therapeutics, Inc. (2012 - Present)
- Scientific Advisory Board, Cure Alzheimer's Fund (2012 - Present)
- Council, American College of Neuropsychopharmacology (2012 - 2015)
- Scientific Advisory Board, International Mental Health Research Organization (2010 - Present)
- Board of Directors, The Brain Research Foundation (2010 - Present)
- Scientific Advisory Board, Pfizer, Inc. (2008 - 2011)
- Scientific Advisory Board, Stanley Center for Psychiatric Research, Broad Institute, Harvard/MIT (2006 - 2016)
- Scientific Advisory Board, Seaside Therapeutics, Inc. (2006 - 2015)
- Council, Society for Neuroscience (2006 - 2010)
- Scientific Council, NARSAD, Brain and Behavior Research Foundation (2001 - Present)
- Scientific Advisory Board, Merck, Inc. (2000 - 2008)
- Scientific Advisory Board, Renovis, Inc. (2000 - 2008)
- Program Committee, Society for Neuroscience (1999 - 2004)
Education
- Residency in psychiatry: Stanford University
- Postdoctoral research: University of California, San Francisco (UCSF)
- MD: Stanford University School of Medicine
- PhD in neuroscience: Stanford University School of Medicine
- Undergraduate: Harvard College
